glp-1 without diabetes Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response A new review by Clifford

Gearhardt, A

Our better understanding of the weight regulation mechanisms and the role of gut-brain axis on appetite has led to the development of safe and effective entero-pancreatic hormone-based treatments for obesity such as glucagon-like peptide-1 (GLP-1) receptor agonists (RA)

If following a diabetes-friendly eating plan hasnt adequately controlled blood sugar levels, you may be a good candidate for Ozempic

2011, pp

Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates

Most treatment discontinuations were due to gastrointestinal AE and occurred during the rapid escalation phase this may be mitigated with more gradual dose escalation at phase 3 trials